Curis, Inc. (CRIS) - NASDAQ
Company Description
Curis, Inc. is a biotechnology company, which is focused on the development and commercialization of innovative drug candidates for the treatment of human cancers. Its pipeline includes is CUDC-907, an orally-available, small molecule inhibitor of histone deacetylase, or HDAC, and... More
Sector: Healthcare
Industry: Biotechnology
Country: United States